Related references
Note: Only part of the references are listed.Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom
Luigino Calzetta et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Protostane-type triterpenoids as natural soluble epoxide hydrolase inhibitors: Inhibition potentials and molecular dynamics
Cheng-Peng Sun et al.
BIOORGANIC CHEMISTRY (2020)
SARS-CoV-2: a storm is raging
Savannah F. Pedersen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)?
Bruce D. Hammock et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis
Sandra Codony et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial
Bruno M. Tomazini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Soluble Epoxide Hydrolase Regulation of Lipid Mediators Limits Pain
Karen M. Wagner et al.
NEUROTHERAPEUTICS (2020)
Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain
Kin Sing Stephen Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Phytochemical constituents from Scutellaria baicalensis in soluble epoxide hydrolase inhibition: Kinetics and interaction mechanism merged with simulations
Zhong-Bo Liu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor
Allison Gartung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain
Rene Blocher et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Treatment of Sepsis Pathogenesis with High Mobility Group Box Protein 1-Regulating Anti-inflammatory Agents
Wansang Cho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis
Carolin Fleischmann et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor
Aili L. Lazaar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain
Bora Inceoglu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Lipoxin Generation Is Related to Soluble Epoxide Hydrolase Activity in Severe Asthma
Emiko Ono et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health
Christophe Morisseau et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Severe Sepsis and Septic Shock REPLY
Derek C. Angus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Severe Sepsis and Septic Shock
Derek C. Angus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pharmacokinetics and Pharmacodynamics of AR9281, an Inhibitor of Soluble Epoxide Hydrolase, in Single- and Multiple-Dose Studies in Healthy Human Subjects
Dawn Chen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Discovery of Inhibitors of Soluble Epoxide Hydrolase: A Target with Multiple Potential Therapeutic Indications
Hong C. Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Effect of Renal Impairment on the Pharmacokinetics of Memantine
Takashi Moritoyo et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2012)
Stimulation of Host Immune Defenses by a Small Molecule Protects C. elegans from Bacterial Infection
Read Pukkila-Worley et al.
PLOS GENETICS (2012)
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
John D. Imig et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
EET displays anti-inflammatory effects in TNF-α-stimulated human bronchi
Caroline Morin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
The soluble epoxide hydrolase as a pharmaceutical target for hypertension
Nipavan Chiamvimonvat et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Development of a high-throughput screen for soluble epoxide hydrolase inhibition
Nicola M. Wolf et al.
ANALYTICAL BIOCHEMISTRY (2006)
Soluble epoxide hydrolase is a therapeutic target for acute inflammation
KR Schmelzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
